Logo image
Cancer-associated retinopathy
Journal article   Open access   Peer reviewed

Cancer-associated retinopathy

S M Goldstein, N A Syed, A H Milam, A M Maguire, T J Lawton and C W Nichols
Archives of ophthalmology (1960), Vol.117(12), pp.1641-1645
12/1999
DOI: 10.1001/archopht.117.12.1641
PMID: 10604671
url
https://doi.org/10.1001/archopht.117.12.1641View
Published (Version of record) Open Access

Abstract

Patients with systemic cancer may have a variety of ocular complaints. Most commonly these are metastases or adverse effects of therapy. Paraneoplastic syndromes, like cancer-associated retinopathy, rarely cause ophthalmic symptoms. We describe a patient with a malignant mixed mullerian tumor and cancer-associated retinopathy who had circulating serum antibodies to recoverin and cells positive for recoverin in the tumor. We discuss the typical clinical symptoms as well as the pathophysiology of this uncommon disorder.
Retinal Diseases - immunology Uterine Neoplasms - pathology Humans Middle Aged Recoverin Visual Fields Antineoplastic Agents, Hormonal - therapeutic use Antigens, Neoplasm - blood Fatal Outcome Retinal Diseases - pathology Female Uterine Neoplasms - radiotherapy Hippocalcin Paraneoplastic Syndromes - immunology Calcium-Binding Proteins - blood Fluorescent Antibody Technique, Indirect Electroretinography Mixed Tumor, Mullerian - radiotherapy Nerve Tissue Proteins Visual Acuity Mixed Tumor, Mullerian - pathology Biomarkers, Tumor - blood Lipoproteins Paraneoplastic Syndromes - pathology Paraneoplastic Syndromes - drug therapy Retinal Diseases - drug therapy Eye Proteins Fundus Oculi Mixed Tumor, Mullerian - immunology Prednisone - therapeutic use Uterine Neoplasms - immunology

Details

Metrics

Logo image